Clinical Trial Update: A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients [Phase 1]

View source ↗

Summary

This is a Phase I study evaluating conditioning with bendamustine and melphalan followed by autologous stem cell transplantation for elderly patients with multi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Melphalan (Melphalan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING